What is Perspective Therapeutics's PP&E (net)?

Perspective Therapeutics (CATX) reported PP&E (net) of $92.48M in Q1 2026.

How has Perspective Therapeutics's PP&E (net) changed year-over-year?

Perspective Therapeutics's PP&E (net) increased by 51.0% year-over-year, from $61.25M to $92.48M.

What is the long-term trend for Perspective Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Perspective Therapeutics's PP&E (net) has grown at a 111.0% compound annual growth rate (CAGR), from $1.83M to $76.6M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Perspective Therapeutics CATX PP&E (Net)

PP&E (Net) at other companies

Eli LillyLLY

$26.54B+43.7%

CytomX TherapeuticsCTMX

$1.09M-51.1%

ImmunomeIMNM

$17.08M+55.9%

Viridian Therapeutics, Inc.VRDN

$1.13M-2.8%

Lantheus HoldingsLNTH

$157.56M-12.8%

uniQureQURE

$12.01M-33.6%

Other financials

Income statement

See full

Revenue$2.2M+27.3%

Gross profit$738.0K+78.3%

Operating income-$28.3M-29.5%

Net income-$26.2M-44.1%

EPS (diluted)-$0.250.0%

Balance sheet

See full

Cash & equivalents$54.0M+21.5%

Total debt$4.2M+10.9%

Total equity$347.4M+22.1%

Total assets$410.8M+24.7%

Cash flow

See full

Operating cash flow-$31.5M-45.8%

CapEx$6.9M+47.3%

Free cash flow-$38.3M-46.1%

Valuation

See full

Market cap$342.14M+33.2%

Enterprise value$292.34M+35.2%

P/S34.2×+19.6×

Profitability

See full

Gross margin33.1%-7.1pp

Operating margin-292.7%-553pp

Net margin-218.4%-781pp

FCF margin-1,073.3%—

Returns & leverage

See full

Return on equity-35.2%+2.3pp

Debt / equity0×0.0×

Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Perspective Therapeutics's PP&E (net)?: Perspective Therapeutics (CATX) reported PP&E (net) of $92.48M in Q1 2026.
How has Perspective Therapeutics's PP&E (net) changed year-over-year?: Perspective Therapeutics's PP&E (net) increased by 51.0% year-over-year, from $61.25M to $92.48M.
What is the long-term trend for Perspective Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Perspective Therapeutics's PP&E (net) has grown at a 111.0% compound annual growth rate (CAGR), from $1.83M to $76.6M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.